*0011028464
*00520190130095944.0
*007ta
*008130827s2002    xx#           000 u eng d
*00901259caa a2200277 c 4500
*019  $bk
*035  $a(EXLNZ-47BIBSYS_NETWORK)990312063284702201
*035  $a(NO-TrBIB)031206328
*035  $a031206328-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*1001 $aDalgard, Olav$d1961-$0(NO-TrBIB)90061647$_66710100
*24510$aThyroid dysfunction during treatment of chronic hepatitis C with interferon alpha :$bno association with wither dosage or efficacy of therapy$cOlav Dalgard...[et al.]
*260  $c2002
*300  $as. 400-406
*500  $aØvrige forfattere: K. Bjøro, K. Hellum, B. Myrvang, T. Bjøro, E. Haug, H. Bell
*653  $aaker$auniversitetssykehus$amedisinsk$aklinikk$aserviceklinikk$ahormonlaboratoriet$_125666100
*7001 $aBell, Helge$d1946-2004$0(NO-TrBIB)90183917$_79476400
*7001 $aBjøro, K.$0(NO-TrBIB)1028017$_125422900
*7001 $aBjøro, Trine$d1955-$0(NO-TrBIB)90224604$_43227300
*7001 $aHaug, Egil$d1938-$0(NO-TrBIB)90625793$_22372700
*7001 $aHellum, K.$0(NO-TrBIB)1028016$_125405700
*7001 $aMyrvang, Bjørn,$d1940-$0(NO-TrBIB)90120048$_73827300
*7730 $tJournal of internal medicine (trykt utg.).$dOxford : Blackwell Scientific Publ.$g251(2002)nr 5$x0954-6820$w998903118704702201$w(NO-LaBS)436904(tnr)
*901  $a80
*999  $aoai:nb.bibsys.no:990312063284702202$b2021-11-01T03:16:02Z$z990312063284702202
^